Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
synthetic catecholamine |
| gptkbp:approvedBy |
1978
|
| gptkbp:ATCCode |
C01CA07
|
| gptkbp:CASNumber |
343-15-7
|
| gptkbp:chemicalFormula |
C18H23NO3
|
| gptkbp:contraindication |
idiopathic hypertrophic subaortic stenosis
|
| gptkbp:discoveredBy |
gptkb:Eli_Lilly_and_Company
|
| gptkbp:eliminationHalfLife |
2 minutes
|
| https://www.w3.org/2000/01/rdf-schema#label |
dobutamine
|
| gptkbp:KEGGID |
D07862
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
increases cardiac contractility
beta-1 adrenergic agonist |
| gptkbp:meltingPoint |
198-199°C
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:PubChem_CID |
CHEMBL1531
36811 DB00841 |
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
gptkb:arrhythmia
hypertension angina tachycardia |
| gptkbp:solubility |
water soluble
|
| gptkbp:UNII |
KJZ4T0802F
|
| gptkbp:usedFor |
heart failure
cardiogenic shock cardiac stress testing |
| gptkbp:bfsParent |
gptkb:Beta-1_adrenergic_receptor
gptkb:beta-adrenergic_receptors |
| gptkbp:bfsLayer |
7
|